New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome (Q37828086)

23 August 2017

1 reference

title

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome (English)

1 reference

23 August 2017

Michael van Husen

1

1 reference

23 August 2017

Markus J Kemper

series ordinal

2

1 reference

23 August 2017

publication date

13 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

26

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

881-892

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-010-1717-5

23 August 2017

exact match

0 references

cites work

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

1 reference

12 December 2020

A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis

1 reference

12 December 2020

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity

1 reference

12 December 2020

A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children

1 reference

12 December 2020

Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome.

1 reference

12 December 2020

FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy

1 reference

12 December 2020

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

1 reference

12 December 2020

Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Non-corticosteroid treatment for nephrotic syndrome in children

1 reference

12 December 2020

Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome

1 reference

12 December 2020

Tacrolimus in the treatment of idiopathic nephrotic syndrome.

1 reference

12 December 2020

Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome

1 reference

12 December 2020

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

1 reference

12 December 2020

Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children.

1 reference

12 December 2020

Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.

1 reference

12 December 2020

Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome

1 reference

12 December 2020

Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?

1 reference

12 December 2020

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

12 December 2020

Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children

1 reference

12 December 2020

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

1 reference

12 December 2020

Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated

1 reference

12 December 2020

Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Cyclosporin A absorption profiles in children with nephrotic syndrome

1 reference

12 December 2020

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

1 reference

12 December 2020

Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?

1 reference

12 December 2020

Vincristine treatment in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Remission of refractory minimal change nephrotic syndrome after basiliximab therapy

1 reference

12 December 2020

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis

1 reference

12 December 2020

Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center

1 reference

12 December 2020

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus

1 reference

12 December 2020

Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivity

1 reference

12 December 2020

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

1 reference

12 December 2020

Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?

1 reference

12 December 2020

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children

1 reference

12 December 2020

Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial

1 reference

12 December 2020

Rituximab for refractory focal segmental glomerulosclerosis

1 reference

12 December 2020

Non-corticosteroid treatment for nephrotic syndrome in children

1 reference

12 December 2020

Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis

1 reference

12 December 2020

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

1 reference

12 December 2020

Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.

1 reference

12 December 2020

Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment

1 reference

12 December 2020

Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus

1 reference

12 December 2020

Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome

1 reference

12 December 2020

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

1 reference

12 December 2020

Management patterns of childhood-onset nephrotic syndrome

1 reference

12 December 2020

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Differential risk of remission and ESRD in childhood FSGS.

1 reference

12 December 2020

Rituximab in refractory nephrotic syndrome.

1 reference

12 December 2020

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

1 reference

12 December 2020

Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome

1 reference

12 December 2020

Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies

1 reference

12 December 2020

Rituximab in patients with the steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome

1 reference

12 December 2020

Fatal pulmonary fibrosis after rituximab administration

1 reference

12 December 2020

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases

1 reference

12 December 2020

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

1 reference

12 December 2020

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

1 reference

12 December 2020

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

1 reference

12 December 2020

Evaluation and management of steroid-sensitive nephrotic syndrome

1 reference

12 December 2020

Treatment practices of FSGS among North American pediatric nephrologists

1 reference

12 December 2020

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children

1 reference

12 December 2020

Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

1 reference

12 December 2020

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

1 reference

12 December 2020

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome

1 reference

12 December 2020

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.

1 reference

12 December 2020

Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome

1 reference

12 December 2020

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

12 December 2020

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report

1 reference

12 December 2020

Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook

1 reference

12 December 2020

Is there a role for vincristine in nephrotic syndrome?

1 reference

12 December 2020

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

12 December 2020

Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus

1 reference

12 December 2020

Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations

1 reference

12 December 2020

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome

1 reference

12 December 2020

Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A?

1 reference

12 December 2020

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

10.1007/S00467-010-1717-5

Identifiers

DOI

1 reference

23 August 2017

1 reference